title: B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation.
authors.affiliation: Cardioendocrine Research Group, University of Otago, Christchurch, New Zealand. mdcarthu@nus.edu.sg
authors.forename: A Mark
authors.initials: AM
authors.lastname: Richards